F. Leperlier

发表

Is low anti-Mullerian hormone (AMH) level a risk factor of miscarriage in women <37 years old undergoing in vitro fertilization (IVF)?

A. Reignier, P. Barrière, T. Fréour, 2021, Human fertility.

Efficacy of assisted reproductive technology after ovarian tissue transplantation in a cohort of 11 patients with or without associated infertility factors

A. Neuraz, L. Selleret, N. Boissel, 2021, Journal of Assisted Reproduction and Genetics.

Abstract P4-16-02: Fertility preservation before neoadjuvant or adjuvant chemotherapy for breast cancer: Final results of PRESAGE trial

M. Campone, S. Lavau, C. Lefeuvre-plesse, 2019, Poster Session Abstracts.

Ovarian reserve and response to stimulation in women undergoing fertility preservation according to malignancy type.

A. Reignier, P. Barrière, T. Fréour, 2018, Reproductive biomedicine online.

A pilot study comparing corifollitropin alfa associated with hp-HMG versus high dose rFSH antagonist protocols for ovarian stimulation in poor responders

A. Reignier, P. Barrière, T. Fréour, 2018, Human fertility.

Association between early βhCG kinetics, blastocyst morphology and pregnancy outcome in a single-blastocyst transfer program.

A. Reignier, P. Barrière, T. Fréour, 2018, European journal of obstetrics, gynecology, and reproductive biology.

Should Intrauterine Inseminations be Performed under Ultrasound Guidance?

Colombel, P. Barrière, T. Fréour, 2016 .

Female obesity does not impact live birth rate after frozen-thawed blastocyst transfer.

A. Reignier, P. Barrière, T. Fréour, 2020, Human reproduction.

Impact of the duration of oestradiol treatment on live birth rate in Hormonal Replacement Therapy cycle before frozen blastocyst transfer.

P. Gourraud, A. Reignier, P. Barrière, 2023, Human fertility.

Use of Tamoxifene-Controlled Ovarian Hyperstimulation for fertility preservation before breast cancer treatment: a prospective cohort study with a 5-year follow-up

A. Dezellus, F. Leperlier, A. Gremeau, 2024, The Breast.